Callan Family Office, LLC Dexcom Inc Transaction History
Callan Family Office, LLC
- $1.33 Trillion
- Q1 2025
A detailed history of Callan Family Office, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Callan Family Office, LLC holds 7,389 shares of DXCM stock, worth $645,355. This represents 0.04% of its overall portfolio holdings.
Number of Shares
7,389
Previous 3,061
141.39%
Holding current value
$645,355
Previous $238 Million
111.97%
% of portfolio
0.04%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding DXCM
# of Institutions
1,081Shares Held
363MCall Options Held
5.4MPut Options Held
4.3M-
Vanguard Group Inc Valley Forge, PA47.5MShares$4.14 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$3.01 Billion0.09% of portfolio
-
State Street Corp Boston, MA16.7MShares$1.46 Billion0.05% of portfolio
-
Baillie Gifford & CO14.2MShares$1.24 Billion0.87% of portfolio
-
Capital Research Global Investors Los Angeles, CA12MShares$1.05 Billion0.19% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $33.7B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...